Health TrialsbyHealthPanel

Prospective Cohort With Incident Stroke

ConditionIschemic Stroke
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorLudwig-Maximilians - University of Munich

About this trial

The primary aim of the study is to derive and validate risk scores for vascular endpoints (recurrent stroke, myocardial infarction, and other complications of stroke) and for death following an incident stroke. For this purpose patients with an incident stroke will be followed for 36 months with additional assessments at 3, 12, 24 and 36 months.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥18 years

Language: German

First ever acute ischemic stroke that occurred with stroke onset in the last 7 days

Written informed consent by patient prior to study participation

Disqualifiers

Prior stroke (definition according to WHO criteria)

Patients presenting brain tumour or brain metastasis

Participation in an intervention- / AMG-study

Trial population

Patients admitted to a specialized stroke service because of an acute stroke

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

850 Participants
are grouped into 1 trial group
Group A: First ever acute ischemic stroke

Trial outcomes

Primary outcomes

1

Combined vascular endpoint composed of stroke, myocardial infarction, and vascular death

This evaluation will be based on a structured interview with the patient. In case of positive screening more information will be obtained by hospital or physician.

Time frame
36 months

Secondary outcomes

1

Combined vascular endpoint composed of stroke, myocardial infarction, and vascular death

This evaluation will be based on a structured interview with the patient. In case of positive screening more information will be obtained by hospital or physician. In case of death of the patient, evaluation will be based on data from the registry office.

Time frame
24 months
2

Combined vascular endpoint composed of stroke, myocardial infarction, and vascular death

This evaluation will be based on a structured interview with the patient. In case of positive screening more information will be obtained by the physician. In case of death of the patient, evaluation will be based on data from the registry office.

Time frame
12 months
3

Course of cognitive function

This evaluation will be based on a structured interview with the patient. In case of positive screening more information will be obtained by the physician.

Time frame
36 months
4

Course of depression

This evaluation will be based on a structured interview with the patient. In case of positive screening more information will be obtained by the physician.

Time frame
36 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Ludwig-Maximilians - University of Munich

Lead sponsor

Charite University, Berlin, Germany

Collaborator

Source ClinicalTrials.gov
Apply now